• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

AMS Publications

1. Werner AA. The male climacteric: report of 273 cases. JAMA 1946; 132:188-94.

2. Bauer J. The male climacteric – a misnomer. JAMA 1944; 126: 914-18 .

3. Degenhardt A. Wechseljahre beim Mann, gibt es sie? In: Fischer S, Streb-Lieder & Vogt, eds. Wechseljahre für Fortgeschrittene. Frankfurt: Verlag für akademische Schriften. 1995: 104-18.

4. McKinlay JB, Longscope CH, Gray A. The questionable physiological and epidemiologic basis for a male climacteric syndrome: preliminary results from the Massachusetts Male Aging Study. Maturitas 1989; 11:103-5.

5. Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C. A New ‘Aging Male’s Symptoms’ (AMS) Rating Scale. The Aging Male 1999; 2:105-114.

6. Heinemann LAJ, Thiel Ch, Assmann A, Zimmermann T, Hummel W, Vermeulen A. Sex differences of “climacteric symptoms” with increasing age? A pooled analysis of cross-sectional population-based surveys. The Aging Male 2000; 3:124-131.

7. Heinemann LAJ, Saad F, Thiele K, Wood-Dauphinee S. The Aging Males’ Symptoms (AMS) rating scale. Cultural and linguistic validation into English. The Aging Male 2001 ; 3:14-22.

8. Herdman M, Fox-Rushby J, Badia X. A model of equivalence in the cultural adaptation of HRQOL instruments: the universalist approach. Qual Life Res 1998; 7: 323-35.

9. Anonymous. Trust introduces new translation criteria. Medical Outcomes Trust Bulletin 1997; 5:2-4.

10. Aaronson NK, Acquadro C, Alonso J et al. International Quality of Life Assessment (IQOLA) project. Quality of Life Research 1992;1:349-351.

11. Acquadro C, Jambon B, Ellis D, Marquis P. Languages and translation issues. Quality of Life and Pharmaco-Econonomics in Clinical Trials, B. Spilker Editor. 2nd Edition;1996: 575-585.

12. Brislin RW. Backtranslation for Cross-Cultural Research. J Cross-Cultural Psychology 1970;1(3):185-216.

13. Brislin RW. Questionnaire Working and Translation. In: Lonner WJ, Thorndike RM (Eds). Cultural Research Methods. John Wiley, New York, 1973:32-58.

14. Brislin RW. The Working and Translation of Research Instruments. In: Lonner WJ, Berry JW (Eds). Field Methods in Cross-Cultural Research. Sage Publications, Beverly Hills, 1968:137-164.

15. Heinemann LAJ, Saad F, Zimmermann T, Novak A, Myon E, Badia X, Potthoff P, T’Sjoen G, Pöllänen P, Goncharow NP, Kim S, Giroudet C. The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions. Health and Quality of Life Outcomes 2003;1:15 (1 May 2003).
http://www.hqlo.com/articles/browse.asp

16. Daig I, Heinemann LAJ, Kim S, Leungwattanakij S, Badia X, Myon E, Moore C, Saad F, Potthoff P, Do Minh T. The Aging Males’ Symptoms (AMS) scale: Review of its methodological characteristics. Health and Quality of Life Outcomes 2003; 1:77 (December 2003). http://www.hqlo.com/content/1/1/77

17. Heinemann LAJ, Saad F, Heinemann K, DoMinh Thai. Can results of the AMS scale predict those of screening scales for androgen deficiency? Aging Male 2004; Submitted for publication.

18. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, Perry III HM. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000; 49:1239-42.

19. Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in aging men. Clinical Endocrinology 2000; 53:703-11.

20. Moore C, Huebler D, Zimmermann T, Heinemann LAJ, Saad F, and Do Minh T. The AMS scale as outcome measure for treatment of androgen deficiency. Eur Urology 2004 ; in press.

21. Jankowska EJ, Szklarska A, Lopuszanska M, Medras M (abstract). Male aging and educational level are strong determinants of the intensity of andropausal symptoms in men in Poland. The Aging Male 2004; 7:17.

22. Jankowska EJ, Lopuszanska M, Szklarska A, Medras M (abstract). Hormonal determinants of andropausal symptoms in polish men. The Aging Male 2004; 7:21.

23. Soh J, Ishida Y, Naito Y, Ochiai A, Naya Y, Mizutani Y, Fujito A, Kawauchi A, Fujiwara T, Tschida H, Fukui K, Miki T(abstract). Correlations of AMS score, depression score and hormonal levels with the manifestations of partial androgen decline in the aging male (PADAM).

24. Itoh N, Hisasue S, Kato R, Tanaka T, Takahashi A, Masumori N, Tsukamoto T (abstract). Comparison of Morley’s ADAM questionnaire and Heinemann’s Aging Male Symptoms (AMS) rating scale to screen andropause symptoms in Japanese males.

25. Heinemann LAJ, Saad F, Pöllänen P. Measurement of Quality of Life Specific for Aging Males. In: Schneider HPG (Ed.) Hormone Replacement Therapy and Quality of Life. Parthenon Publishing Group. London, New York, Washington. 2002: 63-83.

26. Heinemann LAJ, Saad F. The aging male’s symptoms scale. In: Schneider HPG (Ed.) Menopause. The state of the art – in research and management. The Parthenon Publishing Group. Boca Raton, London, New York, Washington. 2003: 319-324.

27. Convay K, Heinemann LAJ, Giroudet C, Johannes EJ, Myon E, Taieb C, Raynaud JP. Harmonized French version of the Aging Males’ Symptoms Scale. Aging Male 2003; 6:106-109.

28. Valenti G, Gontero P, Saccò M, Fontana F, Strollo F, Castellucci A, Heinemann LAJ. Harmonized Italian version of the Aging Males’ Symptoms Scale. Aging Male 2005 (submitted for publication).

29. Heinemann LAJ, Saad F, Heinemann K, DoMinh Thai. Can results of the AMS scale predict those of screening scales for androgen deficiency? Aging Male 2005 (in press)

30. T’Sjoen G, Feyen E, Kuyper P, Comhaire F, Kaufman JM. Self –referred patients in an aging male clinic – much more than androgen deficiency alone. Aging Male 2003;6:157-165.

31. Dunbar N, Gruman C, Reisine S, Kenny A. Comparison of two health status measures and their associations with testosterone levels in older men. Aging Male 2001;4:1-7.

32. Kratzik CW, Reiter WJ, Riedl AM, Lunglmayr G, Brandstätter N, Rücklinger E, Metka M, Huber J. Hormone profiles, Body Maß Index and Aging Male Symptoms – results of the Androx Vienna Municipality study. Aging Male 2004;7:188-96.

33. Gontero P, Carboni F, Longoni C, Galzerano M, Parola A, Buffa B, Alberti E, Fontana F, Frea B, Heinemann LAJ (abstract). Aging male symptoms (AMS) scale scoring in a randomly screened male population of North Italy. J Sex Med 2005;Suppl 1,P-048: 52.

34. Myon E, Martin N, Taïeb C, Heinemann LAJ. Experiences with the French Aging Males’ Symptoms (AMS) scale. Aging Male 2005, in press.

35. Myon E, Martin N, Taieb C. The French aging Males’ Symptoms (AMS) scale: Methodological review. Health and Quality of Life Outcomes 2005, 3:20 (24 March 2005). http://www.hqol.com/content/3/1/21 36] Valenti G, Gontero P, Saccò M, Fontana F, Strollo F, Castellucci A, Heinemann LAJ. Harmonized Italian version of the Aging Males’ Symptoms Scale. Aging Male 2005;8(3/4):180-183.

37. Kratzik C, Heinemann LAJ, Saad F, DoMinh T, Rücklinger E. Composite screener for androgen deficiency related to the Aging Males’ Symptoms scale. Aging Male 2005;8 (3/4):157-161.

38. Heinemann LAJ, Moore C, Dinger J, Stoehr D. Sensitivity as outcome measure of androgen replacement: the AMS scale. Health and Quality of Life Outcomes 2006;4:23. www.hqlo.com/content/4/1/23.

39. Heinemann LAJ. Aging males’ symptoms: AMS scale – a standardized instrument for the practice. J Endocrinol Invest 2005; 28: 34-38.

sidebar

Aging Male Symptoms Scale

  • About AMS
  • Self-assessment
  • Languages
  • Development
  • Psychometric Characteristics
  • Correlation with other scales
  • AMS – properties as an outcome measure
  • AMS – properties as a screening tool
  • AMS Publications

To All Diagnostic Tools

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.